# Top 50 Biotechnology VC (Venture Capital) Funds in Oceania in October 2023

## Uniseed Ventures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 21
- Stages: Series A, Seed
- Focus: Biotechnology, Manufacturing, Health Care

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Brandon Capital Partners
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 15
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

## Medical Research Commercialisation Fund (MRCF)
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 11
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

## Stoic VC
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 7
- Stages: Seed, Series A
- Focus: Biotechnology, Medical, Health Care

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

## Icehouse Ventures
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 7
- Stages: Seed, Series A
- Focus: Software, SaaS, Information Technology

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

## OneVentures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 6
- Stages: Series A, Debt Financing
- Focus: Software, Health Care, Information Technology

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

## Artesian VC
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 5
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Information Technology

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

## Melbourne Angels
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 5
- Stages: Angel, Seed
- Focus: Biotechnology, Information Technology, Manufacturing

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

## New Zealand Venture Investment Fund
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 5
- Stages: Seed, Series A, Angel
- Focus: Software, Biotechnology, SaaS

Your guide to finding and using government services.

## Enterprise Angels
- Type: VC Fund
- Location: Tauranga, Gisborne, New Zealand
- Relevant deals: 5
- Stages: Seed, Angel
- Focus: Software, Information Technology, Health Care

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

## Main Sequence Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 4
- Stages: Series A, Seed, Series B
- Focus: Software, Artificial Intelligence, Information Technology

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

## K1W1
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Biotechnology, SaaS

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

## Clean Energy Finance Corporation
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 3
- Stages: Series B, Series A, Seed
- Focus: Energy, Solar, Renewable Energy

The Clean Energy Finance Corporation invests, applying commercial rigour, to increase the flow of finance into the clean energy sector. Their mission is to accelerate Australia's transformation towards a more competitive economy in a carbon constrained world, by acting as a catalyst to increase investment in emissions reduction. They do thisthrough an investment strategy focused on cleaner power solutions, including large and small-scale solar, wind and bioenergy; and a better built environment, with investments to drive more energy efficient property, vehicles, infrastructure and industry. The CEFC also invests with co-financiers to develop new sources of capital for the clean energy sector, including climate bonds, equity funds, aggregation facilities and other financial solutions. The CEFC operates under the Clean Energy Finance Corporation Act 2012.

## Finistere Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 3
- Stages: Series B, Series C, Series A
- Focus: Agriculture, Biotechnology, Farming

Finistere Ventures is an agricultural technology and life sciences venture capital investor. Founded in 2005, the company partners with other entrepreneurs and creative thinkers to build innovative companies that have the potential to transform modern agriculture, increase food security, improve nutrition, and enhance sustainability. Their appliedexperience as operators, and pioneering role in Ag Tech, is actively utilized to benefit its portfolio companies and Partners. Finistere has global access to the best new technologies from centers of Ag Tech excellence in the U.S., Australia, Israel, New Zealand, and Canada through its venture partner networks. Finistere’s locations in San Diego and Palo Alto, California keeps them connected to the centers of mainstream venture investment and the world’s leading innovation ecosystem.

## Yuuwa Capital
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 3
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Analytics, Health Care

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

## Starfish Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Software, Enterprise Software, Information Technology

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

## Matū Fund
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 3
- Stages: Seed
- Focus: Biotechnology, Robotics, Nanotechnology

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Artificial Intelligence, Software

Investing in the deep science and technology that can propel humanity towards a radically better future.

## BridgeLane Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series B
- Focus: Software, Financial Services, Health Care

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

## IP Group
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Health Care, Biotechnology, Therapeutics

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

## Global Health Investment Fund (GHIF)
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Health Care, Biotechnology, Medical Device

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

## Folklore Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Apps, Information Technology

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

## Grok Ventures
- Type: VC Fund
- Location: Surry Hills, New South Wales, Australia
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Renewable Energy, Software, Internet of Things

Grok Ventures is a private investment company. They back world-class teams solving big problems to shape a better future. They invest in fast growing technology-enabled businesses.

## Sydney Angels
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Angel
- Focus: Software, SaaS, Apps

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

## South Australian Venture Capital Fund
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, SaaS

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

## Vectr
- Type: VC Fund
- Location: Sheung Wan, Hong Kong Island, Hong Kong
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: FinTech, Artificial Intelligence, Financial Services

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

## Lowercarbon Capital
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Biotechnology, Renewable Energy, Energy

Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.

## Possible Ventures
- Type: VC Fund
- Location: Munich, Bayern, Germany
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Information Technology, Biotechnology

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

## Rabobank Food & Agri Innovation Fund
- Type: VC Fund
- Location: Utrecht, Utrecht, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Agriculture, AgTech, Farming

Rabobank emerged from several small agricultural cooperative banks, founded by Dutch farmers in the late nineteenth century. Food & Agriculture (F&A) is in our DNA, from which we built a unique position in the F&A sector as a key financier and international player, attributes which we leverage for the benefit of our stakeholders andportfolio companies. We recognise and understand the food security challenges lying ahead of us and how Innovation in F&A supply chains is key to the solution, which is why we are dedicated to committing capital to the space.

## Brisbane Angels
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 2
- Stages: Seed, Angel
- Focus: Software, Information Technology, Artificial Intelligence

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

## Plymouth Growth
- Type: VC Fund
- Location: Ann Arbor, Michigan, United States
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Software, Information Technology, Enterprise Software

Growth Capital for Leading Midwest Tech Companies

## ATP Innovations
- Type: VC Fund
- Relevant deals: 1
- Focus: Health Care, Biotechnology, Pharmaceutical

ATP Innovations accelerates the growth of technology companies that target global markets, by providing advice and guidance from seasoned entrepreneurs, access to investors, customers and domain specialists, and world-class infrastructure tailored to the needs of startup companies. The ATP Innovations Accelerator HUB is home to Startmate, IgnitionLabs and university accelerator programs. ATP Innovations’ portfolio comprises over 65 companies from the software, hardware and life science sectors.

## Movac
- Type: VC Fund
- Location: Wellington, Wellington, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, E-Commerce, SaaS

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

## Understorey Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Data and Analytics, Information Technology

Understorey Ventures invests in critical solutions needed to restore planetary health.

## NOAB Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: Solar, Energy, Energy Storage

NOAB Ventures operates as a venture capital firm.

## Powerhouse Ventures
- Type: VC Fund
- Location: Christchurch, Canterbury, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Solar, FinTech, Big Data

powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures

## Outset Ventures
- Type: VC Fund
- Location: Parnell, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: CleanTech, Biotechnology, Product Research

Outset Ventures provides investment, facilities, and support for technology on the forefront of new industries to thrive.

## Lilly Ventures
- Type: VC Fund
- Location: Indianapolis, Indiana, United States
- Relevant deals: 1
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Health Care, Therapeutics

Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.

## Bioplatforms Australia
- Type: VC Fund
- Location: Port Macquarie, New South Wales, Australia
- Relevant deals: 1
- Stages: Pre-Seed
- Focus: AgTech, Farming, Agriculture

Bioplatforms Australia is a non-profit entity that supports life science research in genomic, proteomics, metabolomics, and bioinformatics.

## Southern Cross Venture Partners
- Type: VC Fund
- Location: North Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Software, Manufacturing, Renewable Energy

Southern Cross Venture Partners was launched in 2006 by veteran venture capitalists who have managed and operated companies themselves. Southern Cross Venture Partners assist early stage technology companies that demonstrate the potential for exceptional growth and market leadership build significant businesses. The founding principle of SouthernCross is partnership -- they are passionately committed to doing everything they can to help their portfolio companies succeed. Their team has a strong record of utilizing their start-up and management experience, industry knowledge, network of business/customer relationships, and recruiting skills to assist in building significant shareholder value.Southern Cross is currently investing in companies that fit their investment criteria. They prefer to act as lead or co-lead in the early stages where they have experience that can help build value rapidly. They do not have a minimum investment amount, however, a typical initial investment will be $2 million to $5 million with an ability to invest more money in later rounds.

## Grand Challenges Canada
- Type: VC Fund
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Grant, Seed, Debt Financing
- Focus: Health Care, Medical Device, Biotechnology

Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.

## Custos Privatstiftung
- Type: VC Fund
- Relevant deals: 1
- Stages: Series B, Seed, Series C
- Focus: Software, Biopharma, Nutrition

Custos Privatstiftung is a private company.

## Thistledown Capital
- Type: VC Fund
- Location: Ottawa, Ontario, Canada
- Relevant deals: 1
- Stages: Series A
- Focus: Energy, Laser, Electronics

Thistledown Capital is a venture capital firm.

## Empath Ventures
- Type: VC Fund
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Seed, Convertible Note
- Focus: Biotechnology

Empath Ventures is a venture capital firm that mainly invests in psychedelic medicine companies. The firm specializes in the fields of investment financial services, finance, and venture capital.
It was founded in 2021 and headquartered in Los Angeles California.

## Even Capital
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Series C
- Focus: FinTech, Biotechnology, Product Research

Even Capital operates as an investment firm.

## Twynam Agricultural Group
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Agriculture, Food Processing, Seafood

Twynam Group is a leading Australian Funds Manager investing in early-stage climate tech. We also operate an agricultural and property portfolio.

## UniSA Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Software, Health Care, Biotechnology

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

## Investible
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, E-Commerce, Information Technology

Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.

## Playford Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

## HealthCare Ventures
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co